PT - JOURNAL ARTICLE AU - Vincent Chin AU - John P.A. Ioannidis AU - Martin A. Tanner AU - Sally Cripps TI - Effects of non-pharmaceutical interventions on COVID-19: A Tale of Two Models AID - 10.1101/2020.07.22.20160341 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.22.20160341 4099 - http://medrxiv.org/content/early/2020/07/24/2020.07.22.20160341.short 4100 - http://medrxiv.org/content/early/2020/07/24/2020.07.22.20160341.full AB - In this paper, we compare the inference regarding the effectiveness of the various non-pharmaceutical interventions (NPIs) for COVID-19 obtained from two SIR models, both produced by the Imperial College COVID-19 Response Team. One model was applied to European countries and published in Nature 1, concluding that complete lockdown was by far the most effective measure and 3 million deaths were avoided in the examined countries. The Imperial College team applied a different model to the USA states 2. Here, we show that inference is not robust to model specification and indeed changes substantially with the model used for the evolution of the time-varying reproduction number, denoted by Rt. Applying to European countries the model that the Imperial College team used for the USA states shows that complete lockdown has no or little effect, since it was introduced typically at a point when Rt was already very low. We also show that results are not robust to the inclusion of additional follow-up data.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicable.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll source code for the replication of our results is available is available from the Imperial College COVID-19 Response Team's Github repository. Daily confirmed cases and deaths data are publicly available from the European Centre of Disease Control's website.